Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease

Randomized trials of pulmonary vasodilators in pulmonary hypertension due to left heart disease (Group 2) and lung disease (Group 3) have demonstrated potential for harm. Yet these therapies are commonly used in practice. Little is known of the effects of treatment outside of clinical trials. We aim...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pulm Circ
Autores principales: Gillmeyer, Kari R., Miller, Donald R., Glickman, Mark E., Qian, Shirley X., Klings, Elizabeth S., Maron, Bradley A., Hanlon, Joseph T., Rinne, Seppo T., Wiener, Renda S.
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8020250/
https://ncbi.nlm.nih.gov/pubmed/33868640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20458940211001714
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares